Medical House gets US green light

DRUG delivery specialist The Medical House has received clearance to place one of its products in the US market.

The permission from US Food and Drug Administration will enable the Sheffield-based AIM quoted company to market its Compact Auto Safety Injector (CASI) in America.

The CASI will assist the self-administered injection of fixed doses of FDA approved drug products which are presented in pre-filled syringes with staked needles.

The CASI is a version of The Medical House's disposable auto safety injector which is being developed for the global pharmaceutical company which extended its agreement with the South Yorkshire company last November. The deal included an upfront payment of £2m.

Ian Townsend, The Medical House's chairman, said: “This a key milestone achievement for TMH as it is our first ASI device to receive FDA pre-market notification which allows us to market the CASI in the US.

“It is also a vital approval for the project involving our global pharmaceutical partner and its commercial strategy. We are all delighted with this news and we look forward to reporting more progress for our drug delivery division in due course.”